Themis Medicare Limited (BOM: 530199)

India flag India · Delayed Price · Currency is INR
249.80
+8.35 (3.46%)
At close: Sep 10, 2024
48.69%
Market Cap 22.99B
Revenue (ttm) 4.08B
Net Income (ttm) 500.16M
Shares Out 92.04M
EPS (ttm) 5.43
PE Ratio 46.02
Forward PE n/a
Dividend 0.50 (0.21%)
Ex-Dividend Date Jul 12, 2024
Volume 25,475
Open 239.85
Previous Close 241.45
Day's Range 239.85 - 258.75
52-Week Range 142.60 - 279.65
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Nov 14, 2024

About Themis Medicare

Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. The company offers active pharmaceutical ingredients (APIs) and formulations for use in various therapeutic areas, including anti-tuberculosis, anti-malarials, cardiology, pain management, anti-infectives, haematinics, health and nutrition, anaesthesia, gynecology, and orthopedics. It also offers anti-inflammatory drugs and other drugs. The company was formerly known as Themis Chemicals and changed its name to Th... [Read more]

Industry Drug Stores and Proprietary Stores
Founded 1952
Employees 1,509
Stock Exchange Bombay Stock Exchange
Ticker Symbol 530199
Full Company Profile

Financial Performance

In 2023, Themis Medicare's revenue was 3.82 billion, an increase of 7.74% compared to the previous year's 3.54 billion. Earnings were 435.24 million, a decrease of -23.51%.

Financial Statements

News

There is no news available yet.